top of page
Search

MML to develop research and development partnership with Centre Hospitalo-Universitair Mustapha Pacha

CHU Mustapha is the largest hospital in Africa. (French: Centre Hospitalo-Universitaire Mustapha d'Alge) Founded in 1854, it operates as a major university teaching hospital affiliated with University of Algiers and the Algerian Ministry of Health. The hospital has around 1,500 beds and internal research facilities.


MedTech Makers Lab is proud to announce the beginning of a strategic research and development partnership initiative between the United Kingdom and Algeria, centred around collaboration with leading clinical and healthcare stakeholders in Mustapha University Hospital Center and the wider Algerian innovation ecosystem.


As global healthcare systems face mounting pressure from rising patient demand, fragmented supply chains, workforce shortages, and escalating development costs, the need for new cross-border innovation models has become increasingly urgent. Algeria represents a highly underutilised opportunity within the international healthcare and life sciences landscape. With a large clinical population base, expanding scientific capability, and growing appetite for international collaboration, the country is strategically positioned to support the next generation of translational healthcare development.


Through this initiative, MedTech Makers Lab will leverage its expanding operational footprint across the UK and Europe to create a structured bridge between Algerian clinical capability and European innovation delivery systems. Our objective is not simply collaboration for research purposes alone, but the creation of a commercially and clinically aligned ecosystem capable of accelerating development timelines, improving validation pathways, and reducing barriers to market access.


A core component of this strategy will focus on identifying and addressing critical delivery gaps across medtech, diagnostics, digital health, AI-driven healthcare systems, and clinical development infrastructure. Many healthcare innovation systems across Europe continue to suffer from slow deployment cycles, rising operational costs, and insufficient translational capacity between research and commercial execution. We believe Algeria can play an important role in helping reshape this model.


In parallel, we are exploring Algiers as a strategic near-shoring destination for selected healthcare innovation activities. As European companies increasingly seek resilient and cost-effective operational structures closer to their primary markets, Algeria offers compelling geographic and economic advantages. Its proximity to Europe, growing technical workforce, and evolving healthcare infrastructure create opportunities for operational support functions, clinical collaboration programs, data operations, validation studies, and future manufacturing or assembly support in selected sectors.

This initiative will also draw upon MedTech Makers Lab’s broader European network spanning regulatory, clinical, investment, and commercialization expertise across multiple jurisdictions. By integrating UK leadership, EU operational capability, and Algerian clinical and scientific collaboration, we aim to create a new cross-border framework capable of supporting healthcare technologies from early validation through to international deployment.


The future of healthcare innovation will increasingly depend on international partnerships that combine clinical access, operational efficiency, scientific collaboration, and strategic capital alignment. We believe the UK–Algeria corridor has the potential to become an important part of that future.

This is only the beginning.



 
 
 
bottom of page